Oncology Certified Nurse (OCN) Nursing Practice Test

In clinical trials, Phase 1 is specifically designed to evaluate the safety of a new drug or treatment. This phase primarily focuses on determining the maximum tolerated dose (MTD) and identifying any side effects that might occur at varying doses.

During Phase 1 trials, a small group of participants, often healthy volunteers or individuals with the condition under study, receives the drug in increasing doses. The aim is to find the highest dose that can be administered without causing unacceptable side effects. The trial also assesses pharmacokinetics (how the drug is absorbed, distributed, metabolized, and excreted) and preliminary pharmacodynamics (the effects of the drug on the body).

The establishment of the maximum dose without side effects is crucial, as it informs the design of subsequent phases of the trial, which will focus on efficacy and further safety in larger and more diverse populations.

In contrast, the other phases do not primarily focus on dose determination. Phase 4 involves post-marketing studies after a drug has received approval, with emphasis on long-term effects and comparisons to other therapies. Phase 0 is exploratory and involves very small doses to gather preliminary data without establishing a dose-response relationship. Phase 3 focuses on confirming efficacy and monitoring adverse reactions in